Cell Pathways - 500 Beiträge pro Seite

[Plaste]

Hallo Leute,
scheint so, daß es hier so gut wie kaum eine Meinung zu CLPA gibt.
Wenn doch, wäre nett, wenn hier mal jemand eine objektive Meinung zu der Aktie schreiben würde.
mfg Plaste

[Plaste]

Keine Meinungen?

Und nu, vorgestern an der Nasdaq ich glaube 16% und gestern gleich mal 40% ???
Leider hab ich keine News gefunden, die diesen Anstieg rechtfertigen.
Vieleicht weiß ja doch mal jemand was.

[KingsX]

schau mal:

HORSHAM, Pa.--(BUSINESS WIRE)--Aug. 26, 2002--Cell Pathways, Inc.
(Nasdaq:CLPA) today announced the election of Ronald A. Ahrens to the
company`s board of directors. Mr. Ahrens is the retired president of
the Merck Consumer Healthcare Group Worldwide.
"We are very pleased to welcome Ronald Ahrens to the Cell
Pathways` board of directors," said Robert J. Towarnicki, chairman and
chief executive officer of the company. "His great expertise in the
field of consumer healthcare and the management of growing companies
will serve Cell Pathways well as we build Gelclair(TM) sales through a
variety of audiences and advance the development of our novel cancer
therapeutics."
In addition to his experience at Merck & Co., Inc., Ronald Ahrens
has previously held senior management positions at Bristol Myers
Squibb, where he ultimately served as consumer group president, North
America, and at Richardson Vicks Wilton, where he ultimately held the
position of president, Vicks Health Division. He has served on the
executive committee of the Non-Prescription Drug Manufacturing
Association and was a member of the advisory board of the National
Association of Chain Drug Stores. Mr. Ahrens is currently a
non-executive advisor to the board of Johnson & Johnson -- Merck,
chairman of the board of directors of Closure Medical Corporation and
a director of VIASYS Healthcare Inc.